moisture & barrier
Retinol stinging and peeling — is it a sign to stop?
Irritation peaks in the first one to two weeks and eases after — but easing is not disappearing, and 6% stopped altogether. What the evidence says about skin adapting if you keep going, and which reactions mean stop.
Stinging and peeling a few days into retinol sends you looking for an answer, and the answers split cleanly in two. One side calls it an adjustment period and tells you to endure it. The other calls it a damaged barrier and tells you to stop today.
Stinging and flaking are reactions to dial down; swelling, blistering and weeping are signals to stop. The difference between them is one of kind, not of degree.
When is retinol stinging and peeling worst, and when does it ease
In a 44-week study of 355 people using retinoic acid or retinaldehyde, the first-four-week figures of 44% redness, 35% scaling and 29% burning or itching belong to the retinoic acid side; all three were significantly less frequent with retinaldehyde (Fluhr et al., 1999).
Tretinoin gel microsphere 0.1% peaked during the initial two weeks of therapy and decreased thereafter, and adapalene 0.3% gel records irritation as most likely in the first four weeks (FDA labels, RETIN-A MICRO 2025 · DIFFERIN 0.3% 2023). The irritation figures in circulation are mostly prescription numbers, not cosmetic retinol numbers.
Does skin really adapt to retinol if you keep going
The adjustment period is usually called retinization. The word first appears in a 1998 paper describing how to reach that state faster using high-strength tretinoin (Kligman et al., 1998). No controlled trial has tested whether the irritation actually goes away.
In a 12-week double-blind randomised trial with retinol as the comparator arm, moderate and severe irritation had almost cleared by week eight, yet mild redness, mild burning and mild scaling were each still present in 21% of subjects at week 12 (Nguyen et al., 2024). That trial was funded, and its products supplied, by the maker of the ingredient retinol was being compared against.
In the tretinoin gel microsphere label, 14 of 224 subjects — 6% — discontinued because of skin irritation (FDA label, RETIN-A MICRO, 2025).
Does stinging from retinol mean the skin is damaged
Under 48-hour occlusive patches on 42 healthy volunteers, retinoic acid did not raise transepidermal water loss, the measure that rises as the barrier weakens; only the surfactant control did (Fullerton & Serup, 1997). That is a patch irritation test, not a face-application condition. Stinging on its own does not prove the barrier is damaged.
In women with photodamage who applied retinoic acid 0.025% for three months, the stratum corneum thinned by roughly 25% against their own baseline and transepidermal water loss rose by roughly 45% (Jacobson et al., 2007). The placebo control there was for a second ingredient applied alongside, so read both figures as before-and-after. How many weeks the barrier takes to firm up again is set out in how long a damaged skin barrier takes to come back.
Which retinol reactions mean stop
Prescribing information for tretinoin cream and gel states that in certain sensitive users the skin may become excessively red, swollen, blistered or crusted (FDA label, RETIN-A, 2024).
Whether such a reaction is irritant or allergic is not something to sort out alone, so have it looked at. The same document notes severe irritation reported on sunburnt skin, so it is not applied to skin that is sunburnt and has not yet settled. If you are pregnant or planning a pregnancy, take the decision to a doctor — prescribing information says to use topical retinoids only if the potential benefit justifies the potential risk to the fetus (FDA label, RETIN-A, 2024).
If redness arrived together with small bumps, start with retinol purging vs a real breakout.
Retinol splits by kind of reaction, not by time
Adjusting rather than enduring is how people keep using retinol.
Where to start today
- If stinging is interfering with your day, cut frequency to twice a week first. Regulatory documents record irritation peaking in the first one to two weeks and falling after that (FDA label, RETIN-A MICRO, 2025). Give it two weeks; once stinging no longer gets in the way of your day, add one night back at a time.
- If cutting frequency changes nothing, drop the concentration from 0.5% to 0.3%. A 12-week trial found irritation significantly more frequent at 0.5% (Zasada et al., 2020). Give that two weeks too, and if the flaking is less visible, stay at that concentration. If your product was prescribed, take the change to the doctor who prescribed it.
- Swelling, blistering or weeping means stop that day and see a dermatologist. Prescribing information reads irritation at that level as grounds to reduce or stop (FDA label, ATRALIN, 2014). There is no waiting period for these three.
FAQ
References
- FDA label — Bausch Health US, LLC. (2025). RETIN-A MICRO® (tretinoin) gel, 0.1% — Prescribing information, rev. 09/2025 (NDA 020475). U.S. Food and Drug Administration.
- FDA label — Galderma Laboratories, L.P. (2023). DIFFERIN® (adapalene) Gel, 0.3% — Prescribing information, rev. 12/2023. DailyMed.
- FDA label — Bausch Health US, LLC. (2024). RETIN-A® (tretinoin) cream and gel — Prescribing information, rev. 03/2024. DailyMed.
- FDA label — Valeant Pharmaceuticals North America LLC. (2014). ATRALIN® (tretinoin) Gel, 0.05% — Prescribing information, rev. 08/2014 (NDA 022070). U.S. Food and Drug Administration.
- Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M. (1999). "Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions." Dermatology, 199(Suppl 1), 57–60. (PMID 10473963)
- Kligman DE, Sadiq I, Pagnoni A, Stoudemayer T, Kligman AM. (1998). "High-strength tretinoin: a method for rapid retinization of facial skin." Journal of the American Academy of Dermatology, 39(2), S93–S97. (PMID 9703133)
- Nguyen N, Afzal N, Min M, Ahmad N, Afzal L, Burney W, Chambers CJ, Sivamani RK. (2024). "A Prospective, Double-Blinded, Randomized Head-to-Head Clinical Trial of Topical Adapinoid (Oleyl Adapalenate) Versus Retinol." Skin Health and Disease, 4(6), e469. (PMID 39624736)
- Zasada M, Budzisz E, Erkiert-Polguj A. (2020). "A Clinical Anti-Ageing Comparative Study of 0.3 and 0.5% Retinol Serums: A Clinically Controlled Trial." Skin Pharmacology and Physiology, 33(2), 102–116. (PMID 32428912)
- Fullerton A, Serup J. (1997). "Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques." British Journal of Dermatology, 137(2), 234–240. (PMID 9292072)
- Jacobson MK, Kim H, Coyle WR, Kim M, Coyle DL, Rizer RL, Jacobson EL. (2007). "Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage." Experimental Dermatology, 16(11), 927–935. (PMID 17927576)
- Draelos ZD, Baalbaki N, Colon G, Dreno B. (2023). "Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment." Journal of Drugs in Dermatology, 22(6), 554–558. (PMID 37276158)
This article is for general information only and does not replace medical diagnosis or treatment.